To shorten the length of a project, duration compression can be used, such as crashing and fast tracking. On one hand, crashing can result in higher costs, while fast tracking can cause increased work and possibly increased risk. A project manager may decide to use these techniques if they are in a crunch. In that case, the project manager must decide which is the lesser of two evils. How do you think project managers can best make an informed decision about which approach to use? Additionally, the stakes of many medical device projects are high. Do you think it is ever truly safe to use duration compression in high stake medical device projects?
Compressed schedules are often encountered in the development of medical devices, particularly when the team is working under a prominent market opportunity, is facing pressure from investors, or has an urgent clinical need. Although having reduced timelines may bring a competitive advantage, it tends to heighten the risk of errors, quality issues and will increase the possibility of regulatory delays.
In order to use time efficiently under strategic prioritization, teams need to focus on the critical path tasks while ignoring the non-core work components. In addition, there is also the possibility of executing multiple tasks at the same time.
Compliance and product quality are complex concepts combined with accuracy, and doing them all at the same time tends to be a challenge. For instance, saving time on documentation or on testing will lead to cutting corners and pre-emptive blunders, this results in a lot of time wasted later on down the line. It requires high level teamwork, pre-emptive planning with all decision makers/ stakeholders from the beginning, tight coordination and streamlining of every domain of the project to be solved.
Under compressed timelines, what strategies help make sure that compliance and product integrity are maintained? Should the scope be reduced or more resources be allocated to it in order to keep track without quality degradation?
The risks and trade-offs of duration compression in medical device projects are complex. Both crashing and fast tracking can offer time savings, but the potential impact on cost, quality, and compliance makes it something that must be handled carefully. Integrating more iterative or Agile-inspired approaches is one way to manage those risks without sacrificing time. While traditional Agile might not fully align with strict regulatory requirements, principles like early prototyping, continuous testing, and short development cycles can still be adapted to improve flexibility without compromising compliance. Breaking things down into smaller, testable components can sometimes allow for faster progress while still ensuring safety and accuracy. On whether to reduce scope or add resources under time pressure, adding resources tends to be the better long-term solution. Reducing scope might seem efficient at first, but it opens the door to missed functionality, potential rework, or even market failure if key features are cut. By investing more resources, the team can maintain quality and compliance while reducing the risk of issues that could arise later, problems that could be much more costly than any short-term profit loss.
It's never truly safe to use any method that causes an increase to risk or cost. After completing a risk analysis, duration compression should only be used if there's no safer option. In the case of an emergency authorization from the government during a disease outbreak results in the company short on time, and therefore needing to increase costs and/or manual workload, increasing many risks including contamination.
In this case, the benefits outweigh the risk because the public requires an immediate solution. Therefore, risk mitigation strategies should be considered to either reduce, transfer, or accept the risk of an activity. In cases when risk is increased for multiple projects at a time during an emergency outbreak, lag projects are useful in reducing the risk of a project without creating additional delay in the product project lifecycle.
The first step would definitely be to conduct a thorough risk analysis, considering things like the scope, resources, deadlines, and potential impacts on quality. Cost benefit analysis specifically can really help determine what may offer the best balance between saving time, reducing risk, and increasing costs. For medical device projects specifically, risk tolerance is often extremely low and strategies like crashing are almost never worth it because of the high risk they introduce. Quality, specifically safety for the patient, should never be compromised for time. Even if it means extending the timeline for a project, it is more important to maintain the quality of the project especially with extremely strict regulatory guidelines in place with the FDA and other regulatory boards around the world. This keeps the project going in general, as it avoids cutting corners and risking violating any regulatory guidelines or bringing harm to any patient or other company involved or affected by the project.